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Summary 
Data are presented to suggest that a
geographical predisposing factor (G.P.F.)
in multiple sclerosis (M.S.) may reflect regional dietary
differences, and, further, that this factor is directly
related to milk production or consumption. A num-
ber of biochemical hypotheses are proposed which
would predict a resultant weakened blood-brain
barrier or immunological defence, or the production
of defective myelin, which would then increase sus-
ceptibility to the &aelig;tiological agent, possibly a virus.
From the standpoint of brain development, two
different ideas emerge&mdash;one, that differences in the
composition of bovine and human milk, particularly
during weaning, lead to the G.P.F.; the other, that
drinking of milk beyond the normal nursing period is
detrimental. More epidemiological studies are needed,
with emphasis on diet, especially during periods of
rapid brain development. Cow’s milk may be an
unfortunate substitute for human milk in infancy or
a risky food source thereafter, or both. Epidemio-
logical data raise these questions but do not provide
ready answers. The milk correlation could be spuri-
ous, but at least ideas based on such a correlation
pay attention to the most important epidemiological
clue in M.S.&mdash;namely, the geographical distribution of
the disease.
INTRODUCTION
THE peculiar geographical distribution of multiple
* Presented in part at the fifth annual meeting of the American
Society for Neurochemistry, held in New Orleans on
March 13, 1974.
sclerosis (M.S.) has long been a puzzle to researchers.
Within a country, such as the United States, which
spans a great range of latitude, M.S. is more frequent
in colder regions,1 and evidence from different coun-
tries suggests low rates near the equator and increas-
ing rates in temperate zones, with a possible decline
beyond 50-60 degrees of latitude.2 While the actio-
logy and pathogenesis of M.S. remain uncertain, it is
often suggested that the disease may be initiated by
a virus and that its progression may be mediated by
autoimmunity.4 A world map of M.S. shows why
epidemiologists have selected aspects of industrialisa-
tion such as sanitation,s medical facilities,6 socio-
economic status,’ and diet as potential explanations
underlying the correlation between M.s. and latitude,
temperature, and sunlight.9 The putative geographi-
cal predisposing factor (G.P.F.) may be instituted early
in life, since those who emigrate after adolescence
to a country with a low incidence of M.s. seem to
carry risks associated with their country of origin."
Of possible relevance is the rare finding of patho-
logical evidence of M.s. in the brains of adults who
have died of an unrelated disease 11 Since dairy-food
production and consumption is greater in colder
climates within the temperate zone, we wondered if
some aspect of milk consumption could explain the
G.P.F. Rather than usirig the conventional epidemio-
logical procedure of simply reporting correlations
between the variables selected for study and M.S., we
ask whether dairy consumption makes a significant
contribution to the explanation of M.s. after control-
ling for geographical factors and other variables known
to be correlated with nt.s. Is milk consumption simply
a variable whose effect can be accounted for by other
variables, or does it resist statistical elimination?
APPROACHES TO THE EPIDEMIOLOGY OF M.S.
Of the usual numerical representations of the dis-
ease (prevalence, incidence, and mortality) we chose
mortality for a study of the disease in the U.S. Mor-
tality data have some disadvantages. An unknown
fraction (perhaps quite large) of deaths due princi-
pally to M.s. is not so specified on death certificatesP
If there are substantial differences in expectation of
life at birth, similar mortality-rates for different regions
could represent substantial differences in prevalence.
Also, if the G.P.F. exerts its effect at an early age, there
is about a 30-60 year gap between the predisposing
event(s) and death, which should be taken into
account. For example, if a dietary study is corre-
lated with M.S., mortality-rates in 1960 should reflect
the diet in 1900-30. Despite these drawbacks, mor-
tality data do have the important advantage that they
are uniformly available for all American States from
1949, creating a stable data base that is unobtainable
from occasional studies of prevalence or incidence.
We have used all M.s. deaths in the 48 contiguous
States for the period 1949-51, 1953-57, 1958-62,
1963-67-a total of about 26,000 deaths’3 To elimi-
nate the effects of age, race, and sex, we calculated an
expected number of deaths for each State by multiply-
ing the age, race, and sex distribution of each State
by the specific rates for the U.S. within each period.
Our main dependent variable is the ratio of actual
M.s. deaths to expected M.s. deaths for each State.
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For additional stability, we have averaged the four
period ratios.
STUDIES IN THE U.S.
Examination of the relationship between latitude
and the standardised M.S. mortality ratio for Whites
showed that States like Alabama, Georgia, and
Tennessee have only about 50-60% of their predicted
(expected) deaths based on age, sex, and race, while
States such as Wisconsin, Oregon, and Iowa have
40-50% more than their expected share. The cor-
relation between latitude and M.S. is 0-90. When
per-caput milk consumption 14 is compared with
the standardised M.S. mortality ratio the correlation
is 0.82. Both are highly significant. Tables I and
II 15-23 include only part of a larger study of four
types of variables - milk, socioeconomic status,
medical services, and climate or latitude. Our choice
TABLE I-CORRELATIONS OF SELECTED MEASURES OF MILK, MEDICAL
SERVICES, SOCIOECONOMIC STATUS, AND CLIMATE WITH THE
RATIO OF ACTUAL TO EXPECTED M.S. MORTALITY FOR AMERICAN
STATES 1949-67 *
* The mt.s. ratios used in the correlations are an unweighted average
of the M.S. ratios for the periods 1949-51, 1953-57, 1958-62, and
1963-67, derived from the data given in ref. 13. Data on State
populations, 1940-70," were combined with data on milk
measures,"’" socioeconomic status,19,20 medical services,so, 21 and
climate 22,22 to obtain measures of the independent variables.
of variables other than milk was somewhat arbitrary,
but was generally dictated by prior epidemiological
studies. The illness is often described as a disease of
affluence, but it has been hypothesised that the appar-
ent highly patterned geographic distribution actually
reflects differences in available medical care (i.e., M.S.
is more likely to be diagnosed in an affluent popula-
tion). Our U.S. data do not bear this out. The
highest correlations were found with measures of milk
and climate.
Correlations between the independent variables and the
M.S. ratio for non-Whites were low. Differential report-
ing or instability resulting from the small number of
actual and expected cases is probably responsible for the
noted absence of any systematic relationship between
White and non-White disease patterns. Non-White
mortality is about a half of White M.S. mortality: if
valid, this differerice could be explained by differences
in resistance or predisposition to M.S. 21 or to a lower milk
consumption in non-Whites,25 perhaps reflecting the
occurrence of lactose intolerance.26
From only the zero-order correlations in table i, one
might conclude that the correlations between milk measures
and mt.s. are spurious-i.e., that the reason for the cor-
relation is that milk production and consumption are
concentrated in colder climates. In the absence of a
controlled laboratory experiment, one cannot determine
whether or not the relationship is real. We can, however,
determine through regression analysis whether the relation-
ship between milk and M.S. is attributable to the cor-
relation between milk measures and other variables or
whether the milk measures have a unique impact on M.S.
independent of the other variables in the regression
equation (table n). The equations are dominated by
climate (or latitude) and milk, whereas socioeconomic
status and medical services do not have a significant impact
on the M.S. ratio. Clearly, the relationship between milk
and M.S. cannot be attributed to the relationship of milk
with the other variables, including climate or latitude.
Equations 3 and 4 show that a change of one standard
deviation in the milk variable produces a change of 0’4 S.D.
in the mt.s. ratio after adjustment for the other three
variables. When climate or latitude is eliminated (equa-
tion 5), milk is the only other variable that makes a
significant contribution. While the correlation between
milk-fat consumption and M.S. is strongly positive, the
correlation between derived vegetable fat-oil consumption
and M.S. is negative. Southern eating habits include
greater consumption of shortenings, cooking oils, and
salad dressing than in the North.1s Additional correlation
and regression analyses that include other dietary com-
ponents show a negative relationship between M.S. and
TABLE II-REGRESSIONS OF AVERAGE M.S. DEATH RATIOS FOR WHITES ON MILK, MEDICAL SERVICES, SOCIOECONOMIC STATUS, AND CLIMATE
’ 
FOR AMERICAN STATES 1949-67
* Index constructed by regressing the two variables shown in the table on M.S.
t Not statistically significant, o{=0-05 (one-tail).
t Sign reversal.
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TABLE 111-CORRELATIONS OF ANIMAL AND CROP PRODUCT FATS
CONSUMPTION WITH M.S. LEVELS FOR THE O.E.C.D. COUNTRIES*
Austria, Belgium, Canada, Denmark, U.K., Finland, France, Ger-
many, Holland, Italy, Ireland, Japan, New Zealand, Norway,
Portugal, Spain, Sweden, Switzerland, Yugoslavia, United States.
Food-consumption data were obtained from ref. 27. Ordinal
scales of M.S. risk were derived from refs. 28 and 29.
fish intake. Current milk fat consumption and a proxy
for consumption in 1930 (milk production), however,
remain as the most consistent correlative factors in our
data, when several other dietary and non-dietary variables
are used in the equations.
STUDIES IN OTHER COUNTRIES
Using food-consumption data for countries in the
Organisation for Economic Cooperation and Develop-
ment (O.E.C.D.),27 we performed an analysis similar
to that done with the U.S. Comparable mortality,
prevalence, or incidence data were not available for
each country. We therefore utilised published maps
of M.S. density 2s’29 from which we created rough
ordinal scales of high, moderate, and low risks
(table III). Although the published mappings pro-
vide only a rough scale of M.S. risk, the results from
the U.S. were sufficiently intriguing to warrant an
effort with less precise data. The contrast between
the positive correlation of M.S. with animal-product
fats and the negative one with products containing
polyunsaturated fats is striking. In table iv we have
assembled two groups of contrasting countries-the
relatively wealthy O.E.C.D. group and the hetero-
geneous group of European and Near-Eastern coun-
tries used by Leibowitz et aL30 in their analysis of M.S.
among immigrant groups to Israel. The latter partly
overcomes the problem of incomparable data from
different countries and is based on a countrywide
survey of M.S., including re-examination of patients
by a team of neurologists, using fixed diagnostic
criteria. The data for the ordinal scales of M.s. in
the O.E.C.D. countries and the M.s. prevalence-rates
in the other group of countries were compared with
U.N. data 31 for milk-product consumption, popula-
tion per hospital bed, energy consumption, and lati-
tude, corresponding roughly with the four variables
used for the U.S. (tables iv and v). Results were
similar to those seen for the American States, especi-
ally in the O.E.C.D. countries, where living standards
are more comparable to those of the U.S. In this
group of twenty-one countries, milk, even more than
latitude, was the major statistical determinant of M.s.
The importance of affluence and medical facilities as
determining factors was again highly questionable.
TABLE V-REGRESSIONS OF M.S. ON MILK CONSUMPTION, HOSPITAL
FACILITIES, ENERGY CONSUMPTION, AND LATITUDE FOR THREE
SETS OF COUNTRIES
* Not statistically significant, <x == 0-05, one-tail.
t Sign reversal.
In comparing Israeli immigrants from developed
countries such as Britain, Germany, and Holland with
those from underdeveloped countries such as Yemen,
Libya, and Egypt, we obtained a somewhat different
result. Table v shows that in addition to milk and
latitude, affluence does seem to contribute to M.S.
prevalence. The striking similarities involved in corre-
lation and regression when using either prevalence-
rates for Israeli immigrants or the rough ordinal scales
derived from maps should be noted. Leibowitz et al.
noted a high rate of M.s. among native-born Israelis.32
This may reflect the high consumption of dairy
products in Israel relative to Middle Eastern
countries 31
TABLE IV-CORRELATIONS OF MILK CONSUMPTION, HOSPITAL FACILITIES, ENERGY CONSUMPTION, AND LATITUDE WITH SELECTED MEASURES
OF M.S. FOR THREE SETS OF COUNTRIES
’ The Israeli immigrant countries are Aden, Algeria, Austria, Bulgaria, Czechoslovakia, Denmark, Egypt, U.K., Ethiopia, France, Germany, Greece,
Holland, Hungary, Iceland, Iran, Iraq, Israel, Libya, Morocco, Poland, Rumania, Russia, Switzerland, Tunisia, Turkey, Yemen, Yugoslavia.
t Ordinal scales of M.S. were derived from refs. 28 and 29.
t Israeli prevalance data are taken from ref. 30.
&sect; The independent variables come from ref. 31.
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POSSIBLE BIOLOGICAL BASES FOR THE ROLE
OF DAIRY PRODUCTS IN THE G.P.F.
Diet and Latitude
If we accept that the G.P.F. is related to milk con-
sumption, we should next ask how dairy products
affect the brain.
Latitude and dairy fat consumption covary. The
reasons for this are multiple and include economic,
veterinary, and cultural factors 32 Dairy and meat pro-
ducts tend to displace fish and vegetable fats in the
diet in the U.S. when the choice is freely available.18
Since dairy and meat products tend to contain
saturated fats and the fish and vegetables contain poly-
unsaturated fats, the result is a lowering of the amount
of polyunsaturated fat in the diet. In this connection,
it is important to reconsider the age at which the
G.P.F. is established. Epidemiological studies suggest
it is before adulthood.34 The perinatal period may
be especially important. When the brain is still
myelinating and the blood-brain barrier is not yet fully
established, brain structures could be modified as a
result of dietary intake. Human milk differs from
cow’s milk in a number of ways (see below), and there
is no reason to believe that evolution would have
protected us from putative damaging effects of drink-
ing ruminant milk. The world trend away from breast
feeding could result in an increase in M.S. if the G.P.F.
exerts its effect via cow’s milk during infancy. Clausen
and M0ller found that an essential-fatty-acid defi-
ciency in infant guineapigs increased susceptibility to
experimental allergic encephalomyelitis, an animal
disease that is thought to resemble M.S.
Diet might affect the initiating events in M.S. as
well as the progress of the disease throughout life.
Since dietary preferences tend to be established early
in life, the establishment of the G.P.F. before age 15
could simply reflect the formation of dietary habits,
while the progression of the disease could reflect the
consequences of maintenance of the old diet. For
example, the adolescent European immigrant to Israel
probably has a considerably different diet than an
immigrant from Yemen.
Lipids and M.S.
That lipids in the diet can affect the progression of
M.S. is not a new idea.36 For many years, Swank 37
has advocated a low-fat diet, and more recently a
diet high in polyunsaturated fatty acids has been
reported to have beneficial effects on patients with
M.S.38 Bernsohn and Stephanides 8 have pointed out
that these two ideas may not be contradictory, since
a diet high in saturated fat could produce a relative
essential-fatty-acid deficiency. Since the elongation
of fatty-acid chain length in the brain seems to dimi-
nish after the developmental period of rapid myelina-
tion,39 a metabolic basis can be postulated for
permanent alterations in brain lipids as a result of
early diet.
Because M.S. is a demyelinating disease, there have
been numerous biochemical investigations concerning
the composition of myelin of normal and M.S. brain,
and comparisons of plaque lipids with surrounding
brain lipids in M.s. brains In general, there are no
striking differences between normal myelin and non-
affected regions of M.S. brains. The composition of
the plaque itself is intermediate between that of myelin
and normal grey-matter. The region simply shows
the disappearance of myelin. The question then
remains, how could diet lead to the G.P.F.?
Essential-fatty-acid Deficiency or Toxicity ?
A distinction should be made between the two families
of essential fatty acids that man requires in his diet-
those having a double bond three carbons from the methyl
end (<M3 fatty acids) typified by linolenic acid, and those
having a double bond six carbons from the methyl end (m6
fatty acids) typified by linoleic acid. While linoleic and
linolenic acids are present in very low quantities in brain,
their elongated products constitute a major factor of
brain fatty acids, especially in grey-matter.41 In addition
to arachidonic acid (20:4<<)6) and docosahexaenoic acid
(22: 6&)3), smaller quantities of other W6 and M3 poly-
unsaturated acids are also present. The two major poly-
unsaturated acids constitute over 30% of the fatty acids
in human grey-matter phosphatidylethanolamine, and the
minor ones contribute an additional 15 %.42
The reducing atmosphere of the rumen removes linoleic
and linolenic acids, so that they are virtually absent from
milk.43 The combination of dairy products and ruminant
meats thus reduces the total amount of polyunsaturated
fatty acids in the diet. Coastal regions of Norway have
a low incidence of M.S. relative to inland areas,44 in con-
tradiction to the latitude correlation. An even more
dramatic example is Japan in a high-G.P.F. zone by lati-
tude but with little M.S.45 Since coastal communities eat
a lot of fish and since fish is a good source of essential
fatty acids, these observations support the idea that an
essential-fatty-acid deficiency could account for the G.P.F.
Our U.S. data, however, suggest strongly that dairy fat
per se correlates with M.s. mortality, independent of the
negative correlation with fish consumption. In other
words, eating fish may protect to some extent against the
G.P.F. but it does not account for the correlation of M.s.
with milk consumption. We therefore next considered
possible constituents of milk whose presence could account
for the G.P.F.
Milk Lipids
Besides having a relatively low concentration of the
polyunsaturated fatty acids, milk fatty acids are charac-
terised by a great diversity-over 140 fatty acids have been
isolated from milk,46 many of which are either unique to
milk, or are present in milk in higher amounts than in
any other dietary component. There is no evidence for
the accretion of a storage lipid in M.s. Nevertheless,
since there are at least 50 trace fatty acids in milk that
have not been described in other dietary sources, they
must be considered for their possible roles in the G.P.F.
Such fatty acids include those with branched chains (iso-
and anteiso-) or odd-numbered chain lengths and hydroxy
fatty acids. Most of these unusual fatty acids are pro-
duced by the rumen bacteria and are not found in human
milk.47
Short-chain Fatty Acids in Milk
Short-chain fatty acids such as butyrate and hexanoate
are produced by rumen bacteria and are present in milk fat
(see figure). Human milk fat contains no fatty acids
below Clo.47 Short-chain fatty acids (up to hexanoate)
inhibit growth in bacterial and eukaryotic cell cultures.!8
Such substances block transport of aminoacids: parenteral
administration of short and medium chain fatty acids can
produce coma in the rat,49 but the significance of this
finding to human nutrition is questionable, especially since
large amounts of medium-chain fatty acids (octanoate and
1065
Comparison of fatty acids present in bovine and in human milk.
Bovine milk lipids contain butyric (4:0), hexanoic (6:0), and
octanoic (8:0) acids, all absent from human milk. Bovine milk
contains higher amounts of longer-chain saturated fatty acids
and lower amounts of the unsaturated fatty acids than human
milk. It also contains trans fatty acids, primarily ’vaccenic
(18:1, 11-trans), a hexadecenoic acid (16:1, 9-trans), and traces
of their positional isomers, as well as traces of various positional
and geometric isomers of linoleic (18:2) and linolenic (18:3) acids.
decanoate) are well tolerated when ingested as their tri-
glycerides in coconut oil. Whether short-chain fatty acids
in the diet (butyrate or hexanoate) can produce deleterious
effects, notably in the growing brain, is unknown.
Vaccenic Acid
Should there be a toxic lipid in milk that predisposes
to M.S., the trans fatty acid, vaccenic (18:1, 11-trans),
would be an appealing candidate. Linoleic acid and linolenic
acid are reduced in the rumen to a variety of substances,
the most common of which is vaccenic acid. Most of our
knowledge of the metabolism of trans fatty acids relates
to 18:1, 9-trans (elaidic acid) formed in the industrial
hydrogenation of vegetable oils. Significant amounts of
dietary elaidic acid can be incorporated into human tri-
glycerides and structural lipids.5&deg; There are conflicting
reports regarding whether or not trans acids enter the
brain,51.52 and this matter should be reinvestigated. Know-
ledge of the geographical distribution of dietary amounts
of the various trans fatty acids consumed during infancy
would be very useful. Commercial hydrogenation pro-
cesses used for the production of fat have varied over the
past SO years, and it is difficult to assess the relative con-
tribution of milk fats to the total amount of dietary trans
fatty acids. Since the 1950s, most of the trans fatty acids
in the U.S. diet have come via the industrial catalytic
hydrogenation of polyunsaturated vegetable oils. If the
G.P.F. changes in the 1980s, the possible role of trans fatty
acids in M.S. should be considered.
HOW MIGHT DIETARY LIPIDS PREDISPOSE TO M.S.?
The defective membranes formed as a result of diet
could permit easier entry by a causal agent via the
blood-brain barrier or accelerate degradation of myelin
itself. Short-chain fatty acids damage membranes,
and trans fatty acids may be expected to produce
major changes in membrane structure. 53 The free-
dom of motion of trans fatty acids is intermediate
between that of the rigid saturated fatty acid and the
flexible cis form, in monolayers such as must occur
in membranes. This is reflected in the melting-points
of fatty acids. It is also of some possible interest
that, in cow’s milk, trans fatty acid seems to be concen-
trated in sphingomyelin. 54 This phospholipid should
be examined in human tissue for its trans fatty acid
content.
OTHER POSSIBLE TOXIC COMPONENTS OF MILK
We have described a number of bovine components that
might be unhealthy for non-ruminants. A number of
more conventionally toxic substances might also mediate
the G.P.F. For example, the ingestion of peroxidised fats
in stored fodder could result in their presence in milk. It
is also possible that milk contains a toxic subsiance, such
as a trace element, that produces a cumulative effect.
Geological studies suggest that glaciation produced changes
in the soil that could somehow lead to the G.P.F.55 Lactose
could exert a chronic toxic effect. There are few other
dietary sources of galactose, and since the sugar is
metabolised via a specific pathway, it is possible that its
ingestion long after the normal weaning age could have a
deleterious metabolic effect. The known intolerance to
lactose in non-Whites 56 and a low-milk consumption in the
non-White populations in the U.S. might account for
their apparent resistance to the disease.
It has been suggested that galactose arising from dietary
lactose might serve in the biosynthesis of galactocerebro-
side, since myelination is active during nursing, but the
weight of biochemical evidence is against this.57 The
carbohydrates in milk may play an important role in the
immunological development of the infant. Fucosyl and
sialyl lactose are also present in human milk, and in some
species these sugars may even be major milk components.58
Since galactose, fucose, and sialic acid are common deter-
minants of tissue antigens, it is possible that milk carbo-
hydrates play an immunological role, and that the nature
of the carbohydrates and the duration of their ingestion
could have immunological consequences that contribute to
the G.P.F. Human milk contains high concentrations of
inositol, which is quite low in cow’s milk.59
Xanthine oxidase, reportedly found in ruminant but not
in human milk, can be absorbed into the blood.6O It has
been postulated that its adventitious presence can contri-
bute to the atherosclerotic disease process. It might also
mediate the G.P.F. in M.S. An as yet unidentified factor
in cow’s milk has been reported to block cholesterol
synthesis.61
NON-DIETARY EXPLANATIONS OF THE
GEOGRAPHICAL PREDISPOSING FACTOR
The G.P.F. might be accounted for by an infectious
agent such as a slow virus, transmitted by cows.
Indeed, when milk production and milk consump-
tion are simultaneously examined, both variables
contribute significantly to M.S. mortality. Thus,
propinquity to a large cattle population could in itself
predispose to the disease. A report of prevalence of
M.S. among forty occupational groups in Denmark
indicated that the disease was considerably higher
than expected among dairy farmers.62 The correla-
tion could be explained by their higher dairy product
consumption, but it is also possible that dairy farmers
are more likely to be exposed to the putative virus by
contact with the animals or through milk itself.
M.S. is not unique in having a geographical distribu-
tion. Poliomyelitis was found to have a geographical
distribution negatively correlated with sanitation.s A
number of diseases are found in specific climates
because of the existence of various vectors.
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While there is not yet a convincing proposal involv-
ing an infectious agent that accounts for the G.P.F. in
M.S., geographically distributed genetic predisposing
factors may play a role.63 M.S. is much more com-
mon among relatives of M.S. patients than the general
population, and it has been proposed that HL-A
antigen subtypes may carry increased risks of acquir-
ing the disease.64 Since these antigens are distributed
according to geographical patterns, it is possible that
genetic subpopulations could be defined that would
account for some part of the G.P.F.
Requests for reprints should be addressed to D. G., Popula-
tion Studies Center, University of Michigan, 1225 South
University Avenue, Ann Arbor, Michigan 40104, U.S.A.
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Virus Reference Laboratory, Central Public Health
Laboratory, Colindale, London NW9 5HT
Three commercially available tests,
Summary two h&aelig;magglutination and one radio-
immunoassay, were used to test sera received in a
routine clinical laboratory and compared for reli-
ability, convenience, and sensitivity. Their per-
formance was very similar, and, compared with
electrophoresis, the yield of positive results was in-
creased by about 25%.
INTRODUCTION
THE first-generation tests for hepatitis-B antigen
(HBAg)-namely, gel diffusion, electrophoresis, and
complement fixation-are now seen to be relatively
insensitive, but it is not clear which of the newer
more sensitive tests would be most suitable for
routine use. In the Virus Reference Laboratory
three commercially available tests, two hsmag-
glutination (H.A.) and one radioimmunoassay (R.I.A.),
were compared with electrophoresis, and sera giving




The ’ Hepanosticon’ reagent 1 (Organon Scientific
Development Group) uses sheep erythrocytes to which
